Definitive Contract HHSF223201710053C
Award Date
6/1/17
Potential Completion Date
6/30/22
Potential Value
$1.7M
Federal Agency
Food and Drug Administration
Ultimate Awardee
The Commonwealth Of Massachusetts
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH), a state government entity, to provide MASSACHUSETTS MQSA NEW CONTRACT services. The contract has a ceiling value of $2,685,565.04 and a completion date of January 21, 2028. It is a firm fixed price contract and was not set aside. MDPH is a major recipient of federal grants and contracts related to public health programs such as infectious disease...
This is a firm fixed price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Maine Department of Health and Human Services (Maine DHHS) for the Maine MQSA Inspection Program. The contract has a potential value of $200,563.40 and a completion date of September 29, 2022. There was no set-aside designation applied to this award. As the prime contractor, Maine DHHS will provide products and services to support the Mammography...
This is a $451,257.49 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for food inspections in Massachusetts. The contract has a period of performance ending on March 29, 2027 and was awarded on September 12, 2023 without using a set-aside. MDPH, a U.S. state government entity, is the prime contractor and will be conducting the food safety inspections. This contract leverages MDPH's role as the public...
This is a firm fixed-price federal contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH), a state government agency, for food inspections. The contract has a ceiling value of $140,191.49 and an ultimate completion date of September 29, 2005. This contract is not set aside and is part of the MDPH's broader work as a prime contractor and grant recipient providing public health services to federal agencies. MDPH has also been awarded...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
The Food and Drug Administration (FDA) awarded a $236,714.59, firm fixed price definitive contract to the New Hampshire Department of Health and Human Services (NH DHHS) to perform inspections of certified non-federal mammography facilities in New Hampshire. This contract, which runs through March 31, 2028, is to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was not set aside and was competitively awarded to the state agency, which...
This is a federal contract awarded by the Food and Drug Administration (FDA) to the Commonwealth of Virginia State Board of Health Office of Epidemiology Division, doing business as Office of Epidemiology-Central Office. The contract has a ceiling value of $371,732.40 and is a definitive, firm fixed-price contract. The contract period of performance is from September 30, 2015 to September 29, 2016, with one option period. The contract is not set aside. The contract provides for services...
This is a $501,949.66 firm fixed price contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration to the Rhode Island Department of Health to conduct inspections of mammography facilities under the Mammography Quality Standards Act (MQSA) program. The contract has a completion date of January 14, 2028 and was awarded on July 13, 2022. There is no set-aside designation for this contract. As the state public health agency, the Rhode Island Department of...
This firm-fixed-price contract was awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity, to provide Mammography Quality Standards Act (MQSA) inspections. The contract has a ceiling value of $453,010.00 and a period of performance from March 1, 2003, to February 28, 2006. CDPHE, a subsidiary of the City of Lakewood, has a long history of executing federal contracts and grants across various public health...
<p>The Food and Drug Administration (FDA) awarded a firm fixed price definitive contract to the City of New York, through its New York City Department of Health and Mental Hygiene Division (Health Dept), for the implementation of the Mammography Quality Standards Act (MQSA) in New York City. The contract, valued at $3,676,553.75, has an ultimate completion date of March 29, 2028. The contract was awarded on September 22, 2022 and does not have a set-aside designation.</p>